Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shereen Ezzat

Showing results (231-240 of 249) with videos related to

Pageof 25
Sort By:
Cancer Treatment Reviews|May 30, 2016
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensusSimron Singh, Sylvia L Asa, Chris Dey, et al.
Oral Oncology|August 13, 2021
Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancerAndrée Boucher, Shereen Ezzat, Sebastien Hotte, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithmsAnne Kehely, Peter C Bates, Paul Frewer, et al.
World Neurosurgery|November 18, 2020
Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent TumorsAnne-Laure Bernat, Pénélope Troude, Stefano Maria Priola, et al.
British Journal of Cancer|May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trialGrainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
The Journal of Pathology|March 28, 2009
Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinomaDirk Weismann, Juliane Briese, Joscha Niemann, et al.
Cancer Research|March 19, 2009
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formationCraig D Simpson, Imtiaz A Mawji, Kika Anyiwe, et al.
Neurosurgical Review|November 8, 2023
Endoscopic endonasal surgery for prolactinomas: prognostic factors for disease control and management of persistent diseaseAristotelis Kalyvas, Joao Paulo Almeida, Farshad Nassiri, et al.
Plos One|January 15, 2009
The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative studyAnna M Sawka, David P Goldstein, James D Brierley, et al.
Annals of Surgical Oncology|May 23, 2019
Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk DiseasePim J Bongers, Wouter P Kluijfhout, Raoul Verzijl, et al.
Pageof 25

Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
Cancer Treatment Reviews|May 30, 2016
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensusSimron Singh, Sylvia L Asa, Chris Dey, et al.
Oral Oncology|August 13, 2021
Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancerAndrée Boucher, Shereen Ezzat, Sebastien Hotte, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithmsAnne Kehely, Peter C Bates, Paul Frewer, et al.
World Neurosurgery|November 18, 2020
Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent TumorsAnne-Laure Bernat, Pénélope Troude, Stefano Maria Priola, et al.
British Journal of Cancer|May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trialGrainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
The Journal of Pathology|March 28, 2009
Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinomaDirk Weismann, Juliane Briese, Joscha Niemann, et al.
Cancer Research|March 19, 2009
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formationCraig D Simpson, Imtiaz A Mawji, Kika Anyiwe, et al.
Neurosurgical Review|November 8, 2023
Endoscopic endonasal surgery for prolactinomas: prognostic factors for disease control and management of persistent diseaseAristotelis Kalyvas, Joao Paulo Almeida, Farshad Nassiri, et al.
Plos One|January 15, 2009
The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative studyAnna M Sawka, David P Goldstein, James D Brierley, et al.
Annals of Surgical Oncology|May 23, 2019
Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk DiseasePim J Bongers, Wouter P Kluijfhout, Raoul Verzijl, et al.
Pageof 25